Fermenta Biotech Limited (BOM:506414)
468.15
-13.25 (-2.75%)
At close: Sep 25, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 13.42 billion as of September 25, 2026. Its market cap has increased by 35.73% in one year.
Market Cap
13.42B
Enterprise Value
14.17B
Revenue
5.11B
Ranking
n/a
PE Ratio
22.96
Stock Price
468.15
ChartMarket Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 13.42B, an increase of 3,897.09%. That is a compound annual growth rate of 13.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 13.42B | 31.05% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 22.51B |
| Venus Remedies | 22.32B |
| Syncom Formulations (India) | 18.86B |
| Amrutanjan Health Care | 14.63B |
| TTK Healthcare | 14.57B |
| Kopran | 13.75B |
| Bharat Parenterals | 13.06B |
| Lincoln Pharmaceuticals | 11.83B |